Lv61
1780 积分 2025-04-24 加入
Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab–bevacizumab in hepatocellular carcinoma
29天前
已完结
Hepatocellular carcinoma
1个月前
已完结
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases
2个月前
已完结
Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?
2个月前
已关闭
Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
2个月前
已完结
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases
3个月前
已完结
Reply
3个月前
已完结
EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma
4个月前
已完结
Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
4个月前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
4个月前
已完结
皖公网安备34019202002308
